Skip to content

Clinical trials

Esophageal Squamous Cell Carcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Country / region: South Korea Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20111
20124
20131
20151
20161
20173
20184
20193
20205
20217
20221
20233
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting9
Terminated6
Unknown status5
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC6
Samsung Medical Center6
BeiGene4
Hoffmann-La Roche4
AstraZeneca3
Novartis Pharmaceuticals3
Yonsei University3
AbbVie1
Alentis Therapeutics AG1
Asan Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma43
Squamous Cell Carcinoma of Head and Neck12
Carcinoma, Non-Small-Cell Lung7
Esophageal Neoplasms6
Melanoma5
Neoplasm Metastasis5
Stomach Neoplasms5
Uterine Cervical Neoplasms4
Colorectal Neoplasms3
Small Cell Lung Carcinoma3

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.